![Jeffrey Patrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Patrick
Direttore Tecnico/Scientifico/R&S presso NUTRIBAND INC.
Patrimonio netto: 199 535 $ in data 31/05/2024
Profilo
Jeffrey Patrick currently works at Ohio State University Comprehensive Cancer Center, as Director-Drug Development Institute from 2017 and Nutriband, Inc., as Chief Scientific Officer from 2018.
Dr. Patrick also formerly worked at Gilead Sciences, Inc., as Principal, Mallinckrodt Plc, as Vice President-Professional Affairs from 2010 to 2014, Sanofi, Inc., as Principal, Actelion Pharmaceuticals US, Inc., as Principal, New Haven Pharmaceuticals, Inc., as Chief Scientific Officer from 2014 to 2017, the University of Tennessee College of Pharmacy, as Assistant Professor-Pharmacy, and Mallinckrodt Pharmaceuticals Ireland Ltd., as Global Vice President-Professional Affairs from 2010 to 2014.
Dr. Patrick received his doctorate degree from The University of Tennessee Health Science Center.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
NUTRIBAND, INC.
0.33% | 26/04/2024 | 36 612 ( 0.33% ) | 199 535 $ | 31/05/2024 |
Posizioni attive di Jeffrey Patrick
Società | Posizione | Inizio |
---|---|---|
NUTRIBAND INC. | Direttore Tecnico/Scientifico/R&S | 15/05/2018 |
Ohio State University Comprehensive Cancer Center
![]() Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Corporate Officer/Principal | 01/02/2017 |
Precedenti posizioni note di Jeffrey Patrick
Società | Posizione | Fine |
---|---|---|
New Haven Pharmaceuticals, Inc.
![]() New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Direttore Tecnico/Scientifico/R&S | 01/02/2017 |
MALLINCKRODT PLC | Corporate Officer/Principal | 01/08/2014 |
Mallinckrodt Pharmaceuticals Ireland Ltd.
![]() Mallinckrodt Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ireland Ltd. is an Irish specialty pharmaceutical company that has been simplifying complex medical treatments for over 150 years. The company is currently supporting investigator-initiated studies and external collaborative research studies, with a focus on providing hope for patients and families. | Corporate Officer/Principal | 01/08/2014 |
University of Tennessee College of Pharmacy | Corporate Officer/Principal | - |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Formazione di Jeffrey Patrick
The University of Tennessee Health Science Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
NUTRIBAND INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
Aziende private | 5 |
---|---|
New Haven Pharmaceuticals, Inc.
![]() New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
Sanofi, Inc.
![]() Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Actelion Pharmaceuticals US, Inc.
![]() Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Health Technology |
Ohio State University Comprehensive Cancer Center
![]() Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Commercial Services |
Mallinckrodt Pharmaceuticals Ireland Ltd.
![]() Mallinckrodt Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ireland Ltd. is an Irish specialty pharmaceutical company that has been simplifying complex medical treatments for over 150 years. The company is currently supporting investigator-initiated studies and external collaborative research studies, with a focus on providing hope for patients and families. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Patrick